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SummaryBackgroundMultislice CT (MSCT) combined with D-dimer measurement can
safely exclude pulmonary embolism in patients with a low or intermediate clinical
probability of this disease. We compared this combination with a strategy in which
both a negative venous ultrasonography of the leg and MSCT were needed to exclude
pulmonary embolism. Methods We included 1819 consecutive outpatients with
clinically suspected pulmonary embolism in a multicentre non-inferiority randomised
controlled trial comparing two strategies: clinical probability assessment and either
D-dimer measurement and MSCT (DD-CT strategy [n=903]) or D-dimer
measurement, venous compression ultrasonography of the leg, and MSCT (DD-US-CT
strategy [n=916]). Randomisation was by computer-generated blocks with
stratification according to centre. Patients with a high clinical probability according
to the revised Geneva score and a negative work-up for pulmonary embolism were
further investigated in both groups. The primary outcome was the 3-month
thromboembolic risk in patients who were left untreated on the basis of the exclusion
of pulmonary embolism by diagnostic strategy. Clinicians assessing outcome were
blinded to group assignment. Analysis was per protocol. This study is registered with
ClinicalTrials.gov, number NCT00117169. Findings The prevalence of pulmonary
embolism was 20·6% in both groups (189 cases in DD-US-CT group and 186 in DD-CT
group). We analysed 855 patients in the DD-US-CT group and 838 in the DD-CT
group per protocol. The 3-month thromboembolic risk was 0·3% (95% CI 0·1–1·1) in
the DD-US-CT group and 0·3% (0·1–1·2) in the DD-CT group (difference 0·0% [−0·9
to 0·8]). In the DD-US-CT group, ultrasonography showed a deep-venous thrombosis
in 53 (9% [7–12]) of 574 patients, and thus MSCT was not undertaken. Interpretation
The strategy combining D-dimer and MSCT is as safe as the strategy using D-dimer
followed by venous compression ultrasonography of the leg and MSCT for exclusion
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